Frontiers
US$ 27.94
foxo4-dri peptide senolytic human trial Molecular modelling of the FOXO4-TP53 interaction to design peptides for the elimination of senescent cancer cells FOXO4-DRI Peptide - 10 mg
Description
& Croft, P
Peptides are known for their ability to communicate with cells and influence biological processes by binding to specific receptors
2e and f)
Headquartered in Denmark and operating in around 80 countries, Novo Nordisk employs approximately 67,900 people and markets products in roughly 170 countries
